Persistent and selective upregulation of renin–angiotensin system in circulating T lymphocytes in unstable angina

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 18, Issue 1, 2017, Pages 1-8

  Coppo, Mirella ^a   Bandinelli, Manuela ^a   Chiostri, Marco ^a   Poggesi, Loredana ^a   Boddi, Maria ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Angiotensin II; Angiotensin converting enzyme; Renin angiotensin system; T cell; Unstable angina

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; C REACTIVE PROTEIN; GAMMA INTERFERON; RENIN;

ADULT; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; IN VIVO STUDY; INFLAMMATION; LYMPHOCYTE MIGRATION; MALE; PLASMA RENIN ACTIVITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STABLE ANGINA PECTORIS; SUPERNATANT; T CELL CULTURE; T LYMPHOCYTE; UNSTABLE ANGINA PECTORIS; BLOOD; CASE CONTROL STUDY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; UPREGULATION;

ANGINA, UNSTABLE; ANGIOTENSIN II; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-GAMMA; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN; RENIN-ANGIOTENSIN SYSTEM; T-LYMPHOCYTES; UP-REGULATION;

EID: 85017562565     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320317698849     Document Type: Article

References (30)

1. Neri Serneri GG, Boddi M, Modesti PA, et al. Cardiac angiotensin II participates in coronary microvessel inflammation of unstable angina and strengthens the immunomediated component. Circ Res 2004; 94: 1630–1637.
2. Costerousse O, Allegrini J, Lopez M, et al. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290: 33–40.
3. Lazarus DS, Aschoff J, Fanburg BL, et al. Angiotensin converting enzyme (kinase II) mRNA production and enzymatic activity in human peripheral blood monocytes are induced by GM-CSF but not by other cytokines. Biochim Biophys Acta 1994; 1226: 12–18.
4. Gomez RA, Norling LL, Wilfong N, et al. Leukocytes synthesize angiotensinogen. Hypertension 1993; 21: 470–475.
5. angiotensin II is present in human monocytes. Circulation 1995; 91: 1129–1134.
6. Coppo M, Boddi M, Bandinelli M, et al. Angiotensin II upregulates renin-angiotensin system in human isolated T lymphocytes. Regul Pept 2008; 151: 1–6.
7. Sesso HD, Buring JE, Rifai N, et al. C-reactive protein and the risk of developing hypertension. JAMA 2003; 290: 2945–2951.
8. Pedrinelli R, Dell’Omo G, Di Bello V, et al. Low grade inflammation and microalbuminuria in hypertension. Arterioscler Thromb Vasc Biol 2004; 24: 2414–2419.
9. Jurewicz M, McDermott DH, Sechler JM, et al. Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol 2007; 18: 1093–1101.
10. Tousoulis D, Tourikis P, Papageorgiou N, et al. Vascular effects of circulating CD4-T cells in patients with unstable angina. Int J Cardiol 2014; 176: 519–520.
11. Neri Serneri GG, Boddi M, Modesti PA, et al. Immunomediated and ischemia-independent inflammation of coronary microvessels in unstable angina. Circ Res 2003; 92: 1359–1366.
12. Robertson A-KL and Hansson GK. T cells in atherogenesis for better or for worse? Arterioscler Thromb Vasc Biol 2006; 26: 2421–2432.
13. Libby P, Ridker PM and Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129–2138.
14. ACE Inhibitor Myocardial Infarction Collaborative Group. Indications for ACE inhibitors in the early treatment of acute myocardial infarction systematic overview of individual data from 100,000 patients in randomized trials. Circulation 1998; 97: 2202–2212.
15. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensinconverting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145–153.
16. Ellis SG, Lincoff AM, Whitlow PL, et al. Evidence that angiotensin converting enzyme inhibitor use diminishes the need for coronary revascularization after stenting. Am J Cardiol 2002; 89: 937–940.
17. Kranzhofer R, Schmidt J, Pfeiffer CA, et al. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 1623–1629.
18. Wang K, Jin F, Zhang Z, et al. Angiotensin II promotes the development of carotid atherosclerosis in type 2 diabetes patients via regulating the T cells activities: a cohort study. Med Sci Monit 2016; 22: 4000–4008.
19. Hoch NE, Guzik TJ, Chen W, et al. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 2009; 296: R208–R216.
20. Jurewicz M, McDermott DH, Sechler JM, et al. Human T and natural killer cells possess a functional renin angiotensin system: further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol 2007; 18: 1093–1102.
21. Coppo M, Bandinelli M, Berni A, et al. Ang II up-regulation of the T-lymphocyte renin–angiotensin system is amplified by low-grade inflammation in human hypertension. Am J Hypertens 2011; 24: 716–723.
22. Neri Serneri GG, Boddi M, Poggesi L, et al Activation of cardiac renin-angiotensin system in unstable angina. J Am Coll Cardiol 2001; 38: 49–55.
23. Libby P, Okamoto Y, Rocha VZ, et al. Inflammation in atherosclerosis: transition from theory to practice. Circ J 2010; 74: 213–220.
24. Guzik TJ, Hoch NE, Brown KA, et al. The role of T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204: 2449.
25. Zeng KMQ, Lin Y, Wu B, et al. Valsartan attenuates atherosclerosis via upregulating the Th2 immune response in prolonged angiotensin II-treated ApoE-/- mice. Mol Med 2015; 21: 143–153.
26. Methe H, Brunner S, Wiegand D, et al. Enhanced T helper 1 lymphocyte activation patterns in acute coronary syndromes. J Am Coll Cardiol 2005; 45: 1939–1945.
27. Ji QW, Guo M, Zheng JS, et al. Downregulation of T helper cell type 3 in patients with acute coronary syndrome. Arch Med Res 2009; 40: 285–291.
28. Mazzolai L, Duchosal MA, Korber M, et al. Endogenous angiotensin II induces atherosclerotic plaque vulnerability and elicits an Th1 response in ApoE-/- mice. Hypertension 2004; 44: 277–282.
29. Benagiano M, Azzurri A, Ciervo A, et al. T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions. Proc Natl Acad Sci USA 2003; 100: 6658–6663.
30. Engelbertsen D, Andersson L, Ljungcrantz I, et al. T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke. Arterioscler Thromb Vasc Biol 2013; 33: 637–644.